Ovarian hyperstimulation syndrome: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Diagnosis==" to "==Evaluation==") |
(→Workup) |
||
(10 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Fertility treatments causing development of multiple follicles at once | *Fertility treatments causing development of multiple follicles at once | ||
*Fluid shifts out of vasculature | **Exaggerated ovarian response to ovulation induction (esp in IVF when HCG is used to stimulate) | ||
*Fluid shifts out of vasculature (third spacing) | |||
*Typically 5-10d after 1st dose | |||
*Ranges in severity from mild to severe multiorgan dysfunction, relating in part to massive intravascular fluid shifts | |||
==Clinical Features== | ==Clinical Features== | ||
Line 7: | Line 10: | ||
*Movement of fluid out of vasculature | *Movement of fluid out of vasculature | ||
**[[Ascites]] | **[[Ascites]] | ||
**Pleural effusions | **[[Pleural effusions]] | ||
**Pericardial effusion | **[[Pericardial effusion]] | ||
**[[Hypotension]] | **[[Hypotension]] | ||
*[[Electrolyte | *[[Electrolyte imbalances]] | ||
*[[DIC]] | *[[DIC]] | ||
*[[Thromboembolism]] | *[[Thromboembolism]] | ||
Line 17: | Line 20: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
*[[Ectopic | *[[Ectopic pregnancy]] | ||
*Molar | *[[Molar pregnancy]] | ||
*[[Sepsis]] | *[[Sepsis]] | ||
*[[ | *[[Pulmonary embolism in pregnancy]] | ||
{{Pelvic pain DDX}} | {{Pelvic pain DDX}} | ||
==Evaluation== | ==Evaluation== | ||
[[File:Vaginal ultrasonography in mild ovarian hyperstimulation syndrome - sagittal.jpg|thumb|Pelvic ultrasound (sagittal) in woman with OHSS showing ascites and enlarged ovary (diameter = 6.5mm)]] | |||
===Workup=== | ===Workup=== | ||
*Urine pregnancy | *Urine or serum pregnancy | ||
**'''[[Beta-HCG]] may be positive if [[beta-HCG]] injection given as part of fertility treatment''' | **'''[[Beta-HCG]] may be positive if [[beta-HCG]] injection given as part of fertility treatment, consider obtaining beta quantitative instead of qualitative''' | ||
*CBC | *CBC | ||
*Chem 10 | *Chem 10 | ||
*PT/PTT | *PT/PTT | ||
*Pelvic ultrasound | *[[Pelvic ultrasound]] | ||
*Consider: | *Consider: | ||
**CXR ( | **[[CXR]] (rule out [[pleural effusion]]) | ||
**Cardiac | **Cardiac [[ultrasound]] (rule out [[pericardial effusion]]) | ||
**Progesterone level | **Progesterone level | ||
**Estradiol level | **Estradiol level | ||
**Fibrinogen ( | **Fibrinogen (rule out [[DIC]]) | ||
===Evaluation<ref>Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil steril 1992; 58:249. From: Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol 2012; 10:32. Copyright © 2012 Fiedler and Ezcurra. Reproduced from BioMed Central Ltd</ref>.=== | ===Evaluation<ref>Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil steril 1992; 58:249. From: Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol 2012; 10:32. Copyright © 2012 Fiedler and Ezcurra. Reproduced from BioMed Central Ltd</ref>.=== | ||
Line 56: | Line 60: | ||
*Ultrasonographic evidence of [[ascites]] | *Ultrasonographic evidence of [[ascites]] | ||
|| | || | ||
*Elevated | *Elevated hematocrit (>41%) | ||
*Elevated WBC (>15,000/mL) | *Elevated WBC (>15,000/mL) | ||
*Hypoproteinemia | *Hypoproteinemia | ||
Line 73: | Line 77: | ||
*[[Venous thrombosis]] | *[[Venous thrombosis]] | ||
|| | || | ||
*Hemoconcentration ( | *Hemoconcentration (hematocrit >55%) | ||
*WBC >25,000/mL | *WBC >25,000/mL | ||
*Serum creatinine >1.6mg/dL | *Serum creatinine >1.6mg/dL | ||
Line 93: | Line 97: | ||
||Worsening findings | ||Worsening findings | ||
|} | |} | ||
==Management== | ==Management== | ||
Line 108: | Line 110: | ||
===Moderate=== | ===Moderate=== | ||
*[[IV fluids]] (e.g normal saline) | *[[IV fluids]] (e.g normal saline) | ||
* | *Therapeutic [[paracentesis]] if [[ascites]] (aspirate 0.5-4 L) | ||
*Thromboembolic prophylaxis (e.g. [[LMWH]]) | *Thromboembolic prophylaxis (e.g. [[LMWH]]) | ||
**All hospitalized patients | **All hospitalized patients |
Latest revision as of 19:06, 15 April 2020
Background
- Fertility treatments causing development of multiple follicles at once
- Exaggerated ovarian response to ovulation induction (esp in IVF when HCG is used to stimulate)
- Fluid shifts out of vasculature (third spacing)
- Typically 5-10d after 1st dose
- Ranges in severity from mild to severe multiorgan dysfunction, relating in part to massive intravascular fluid shifts
Clinical Features
- Ovarian enlargement
- Movement of fluid out of vasculature
- Electrolyte imbalances
- DIC
- Thromboembolism
- Both venous and arterial
- Hypervolemic hyponatremia
Differential Diagnosis
Acute Pelvic Pain
Gynecologic/Obstetric
- Pregnancy-related
- Ectopic Pregnancy
- Spontaneous abortion, threatened or incomplete
- Septic abortion
- Acute Infections
- Vulvovaginitis
- Adnexal Disorders
- Hemorrhage/rupture of ovarian cyst
- Ovarian torsion
- Twisted paraovarian cyst
- Other
- Myoma (degenerating)
- Genitourinary trauma
- Ovarian hyperstimulation syndrome
- Sexual assault
- Recurrent
- Mittelschmerz
- Primary/Secondary Dysmenorrhea
- Pelvic Congestion Syndrome
- Endometriosis
Genitourinary
Gastrointestinal
- Gastroenteritis
- Appendicitis
- Bowel obstruction
- Perirectal abscess
- Diverticulitis
- Inflammatory bowel disease
- Irritable bowel syndrome
- Mesenteric adenitis
Musculoskeletal
- Abdominal wall hematoma
- Psoas hematoma, psoas abscess
- Hernia
Vascular
- Pelvic thrombophlebitis
- Abdominal aortic aneurysm
- Ischemic bowel (Mesenteric Ischemia)
Evaluation
Workup
- Urine or serum pregnancy
- CBC
- Chem 10
- PT/PTT
- Pelvic ultrasound
- Consider:
- CXR (rule out pleural effusion)
- Cardiac ultrasound (rule out pericardial effusion)
- Progesterone level
- Estradiol level
- Fibrinogen (rule out DIC)
Evaluation[2].
Classification | Clinical features | Lab findings |
Mild |
|
Normal |
Moderate | Above plus:
|
|
Severe | Above plus:
|
|
Critical | Above plus:
|
Worsening findings |
Management
Pregnant patients must be followed very closely, as they are likely to worsen
- Urgent GYN consultation for all
Mild
- Pain control
- Acetaminophen, Norco, or morphine
- Encourage oral fluids (1-2 liters/day)
- Ambulate, but avoid other physical activity. Avoid sexual intercourse
Moderate
- IV fluids (e.g normal saline)
- Therapeutic paracentesis if ascites (aspirate 0.5-4 L)
- Thromboembolic prophylaxis (e.g. LMWH)
- All hospitalized patients
- Outpatients with 2-3 risk factors:
- Age >35 years
- Obesity
- Immobility
- Personal or family history of thrombosis
- Thrombophilias
- Pregnancy
Severe
- As above + consider need to drain pleural or pericardial effusion
Critical
- As above + resuscitative care
Disposition
- Mild: outpatient
- Avoid heavy physical activity
- Return for
- Worsening abdominal pain
- Weight gain (>1 kg/day)
- Increasing abdominal girth
- Moderate: outpatient if close follow-up (discuss with GYN)
- Severe: admit
- Critical: ICU
Complications
- Ovarian torsion
- Venous thromboembolism
- Hydrothorax
- Pericardial effusion
- Arterial thrombosis
- Pulmonary embolism
- Sepsis
- Acute renal failure
- Acute respiratory distress syndrome (ARDS)
- Disseminated intravascular coagulation (DIC)
See Also
References
- ↑ Norris DL, Young JD. UTI. EM Clin N Am. 2008; 26:413-30.
- ↑ Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil steril 1992; 58:249. From: Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol 2012; 10:32. Copyright © 2012 Fiedler and Ezcurra. Reproduced from BioMed Central Ltd